Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Curr Pharm Biotechnol ; 22(2): 254-261, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-32515307

RESUMEN

BACKGROUND: Oleamide is an essential substance for human health. So, the plants with high oleamide content are great sources for health care products. OBJECTIVE: This study is conducted to investigate the quality of oleamide in plants and test the bioactivity in the selected two studied species. METHODS: The three Ipomoea and five Dillenia species including Ipomoea alba, Ipomoea aquatica and Ipomoea pes-caprae, and Dillenia indica, Dillenia obovata, Dillenia ovata, Dillenia parviflora and Dillenia pentagyna were investigated for the quantity of oleamide by high-performance liquid chromatography. The biological activity test was conducted on the powder formulation of the chosen plants, Dillenia ovata and Dillenia parviflora at a ratio of 30:70, for anti-inflammatory activity ex vivo on a panel of molecular targets through ion channel inhibition including voltage-gated sodium channel, voltage-gated potassium channel, and the cardiac ion as human ether-a-go-go related gene. RESULTS: The results showed that the leaf extracts of I. aquatica and D. ovata gave the highest and subsequent oleamide quantity i.e. 7.52 and 5.17 mg/g, respectively. Out of the Dillenia formulation which contained various compounds, oleamide showed the highest percentages of inhibition at 8.0-20.0%, and 6.2-14.2% in voltage-gated sodium channel, and voltage-gated potassium channel which had slightly lower values than the oleamide standard, and no effect as 0.0% value inhibition in the cardiac ion channel. CONCLUSION: The Dillenia formulation exhibits anti-inflammatory activity without affecting the heart. Accordingly, the three studied Ipomoea and three studied Dillenia species may be used for the same activity as a single component or formulation with effective solvent for disease treatments.


Asunto(s)
Antiinflamatorios/farmacología , Dilleniaceae , Canales Iónicos/antagonistas & inhibidores , Ipomoea , Ácidos Oléicos/farmacología , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/aislamiento & purificación , Cromatografía Líquida de Alta Presión/métodos , Femenino , Aditivos Alimentarios/aislamiento & purificación , Aditivos Alimentarios/farmacología , Canales Iónicos/metabolismo , Ácidos Oléicos/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Xenopus laevis
2.
Eur J Pharmacol ; 885: 173390, 2020 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-32735983

RESUMEN

Erythrinian alkaloids ((+)-erythravine and (+)-11-α-hydroxy-erythravine) have been pointed as the main responsible agents for the anticonvulsant and anxiolytic properties of Erythrina mulungu Mart ex Benth. The present work provides a new set of information about the mode of action of these alkaloids by the use of a complementary approach of neurochemical and electrophysiological assays. We propose here that the antiepileptic and anxiolytic properties exhibited by both alkaloids appear not to be related to the inhibition of glutamate binding or GABA uptake, or even to the increase of glutamate uptake or GABA binding, as investigated here by the use of rat cortical synaptosomes. Similarly, and even in a high concentration, (+)-erythravine and (+)-11-α-hydroxy-erythravine did not modulate the main sodium and potassium channel isoforms checked by the use of voltage-clamp studies on Xenopus laevis oocytes. However, unlike (+)-11-α-hydroxy-erythravine, which presented a little effect, it was possible to observe that the (+)-erythravine alkaloid produced a significant inhibitory modulation on α4ß2, α4ß4 and α7 isoforms of nicotinic acetylcholine receptors also checked by the use of voltage-clamp studies, which could explain at least partially its anxiolytic and anticonvulsant properties. Since (+)-11-α-hydroxy-erythravine and (+)-erythravine modulated nicotinic acetylcholine receptors to different extents, it is possible to reinforce that small differences between the chemical structure of these alkaloids can affect the selectivity and affinity of target-ligand interactions, conferring distinct potency and/or pharmacological properties to them, as previously suggested by differential experimental comparison between different erythrinian alkaloids.


Asunto(s)
Ansiolíticos/farmacología , Anticonvulsivantes/farmacología , Compuestos Heterocíclicos de 4 o más Anillos/farmacología , Animales , Corteza Cerebral/efectos de los fármacos , Corteza Cerebral/metabolismo , Erythrina/química , Ácido Glutámico/metabolismo , Antagonistas Nicotínicos/farmacología , Oocitos , Técnicas de Placa-Clamp , Potasio/metabolismo , Receptores Nicotínicos/efectos de los fármacos , Canales de Sodio/metabolismo , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Xenopus laevis , Ácido gamma-Aminobutírico/metabolismo
3.
Sci Rep ; 6: 33314, 2016 09 21.
Artículo en Inglés | MEDLINE | ID: mdl-27650866

RESUMEN

Ion channels play a central role in a host of physiological and pathological processes and are the second largest target for existing drugs. There is an increasing need for reliable tools to detect and visualize particular ion channels, but existing solutions suffer from a number of limitations such as high price, poor specificity, and complicated protocols. As an alternative, we produced recombinant chimeric constructs (FP-Tx) consisting of fluorescent proteins (FP) fused with potassium channel toxins from scorpion venom (Tx). In particular, we used two FP, eGFP and TagRFP, and two Tx, OSK1 and AgTx2, to create eGFP-OSK1 and RFP-AgTx2. We show that these chimeras largely retain the high affinity of natural toxins and display selectivity to particular ion channel subtypes. FP-Tx are displaced by other potassium channel blockers and can be used as an imaging tool in ion channel ligand screening setups. We believe FP-Tx chimeras represent a new efficient molecular tool for neurobiology.


Asunto(s)
Bloqueadores de los Canales de Potasio/farmacología , Canales de Potasio con Entrada de Voltaje/antagonistas & inhibidores , Venenos de Escorpión/farmacología , Animales , Células Cultivadas , Evaluación Preclínica de Medicamentos/métodos , Escherichia coli , Proteínas Fluorescentes Verdes/farmacología , Concentración 50 Inhibidora , Potenciales de la Membrana/efectos de los fármacos , Oocitos , Canales de Potasio con Entrada de Voltaje/metabolismo , Proteínas Recombinantes de Fusión/farmacología , Xenopus laevis
4.
Toxicon ; 61: 72-82, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23142506

RESUMEN

In the present study, we report for the first time, the molecular, biochemical and electrophysiological characterization of the components present in the soluble venom from Mesobuthus gibbosus (Brullé, 1832). According to the epidemiological and clinical situation of scorpion envenomation cases M. gibbosus scorpion is one of the most important health-threatening species of Turkey. Despite the medical importance reported for M. gibbosus, there is no additional information on toxin peptides and venom components to clarify the toxic effect of the M. gibbosus sting. Biochemical characterization of the venom was performed using different protocols and techniques following a bioassay-guided strategy (HPLC, mass spectrometry and Edman degradation sequencing). Venom fractions were tested in electrophysiological assays on a panel of six K(+) channels (K(v)1.1-1.6) by using the two-electrode voltage clamp technique. Three new α-KTx peptides were found and called MegKTx1, MegKTx2 and MegKTx3 (M. gibbosus, K(+) channel toxin number 1-3). A cDNA library from the telson was constructed and specific screening of transcripts was performed. Biochemical and molecular characterization of MegKTx peptides and transcripts shows a relation with toxins of three different α-KTx subfamilies (α-KTx3.x, α-KTx9.x and α-KTx16.x).


Asunto(s)
Bloqueadores de los Canales de Potasio/farmacología , Venenos de Escorpión/farmacología , Escorpiones/química , Secuencia de Aminoácidos , Animales , Cromatografía Líquida de Alta Presión , Clonación Molecular , ADN Complementario/genética , Datos de Secuencia Molecular , Oocitos , Técnicas de Placa-Clamp , Péptidos/farmacología , Bloqueadores de los Canales de Potasio/química , Venenos de Escorpión/química , Turquía , Xenopus
5.
Proteomics ; 12(2): 313-28, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22121013

RESUMEN

Venom from the scorpion Pandinus cavimanus was obtained by electrical stimulation of the telson (stinger). Total venom was toxic to crickets at 7-30 µg and a paralysis or lethal effect was observed at 30 µg of venom (death at 1.5 µg/mg of cricket). Electrophysiological analyses showed cytolytic activity of total venom on oocytes at 7 µg. HPLC allowed separation of the venom components. A total of 38 fractions from total venom were tested on voltage-gated Na(+) and K(+) channels. Some fractions block K(+) currents in different degrees. By using MS analysis, we obtained more than 700 different molecular masses from telson and venom fractions (by LC-MS/MS and MALDI-TOF MS analyses). The number of disulfide bridges of the telson components was determined. A cDNA library from P. cavimanus scorpion was constructed and a random sequencing screening of transcripts was conducted. Different clones were obtained and were analyzed by bioinformatics tools. Our results reveal information about new genes related to some cellular processes and genes involved in venom gland functions (toxins, phospholipases and antimicrobial peptides). Expressed sequence tags from venom glands provide complementary information to MS and reveal undescribed components related to the biological activity of the venom.


Asunto(s)
Venenos de Escorpión/química , Escorpiones/química , Secuencia de Aminoácidos , Estructuras Animales/química , Animales , Cromatografía Líquida de Alta Presión , Biología Computacional , Disulfuros/química , Estimulación Eléctrica , Fenómenos Electrofisiológicos , Etiquetas de Secuencia Expresada , Perfilación de la Expresión Génica , Biblioteca de Genes , Gryllidae/efectos de los fármacos , Datos de Secuencia Molecular , Oocitos/efectos de los fármacos , Oocitos/metabolismo , Mapeo Peptídico/métodos , Bloqueadores de los Canales de Potasio/química , Bloqueadores de los Canales de Potasio/toxicidad , Canales de Potasio/metabolismo , Venenos de Escorpión/genética , Venenos de Escorpión/toxicidad , Escorpiones/genética , Canales de Sodio/metabolismo , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Xenopus laevis/metabolismo
6.
Mol Cell Proteomics ; 10(2): M110.002832, 2011 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20889474

RESUMEN

Scorpion toxins affecting K(+) channels (KTxs) represent important pharmacological tools and potential drug candidates. Here, we report molecular characterization of seven new KTxs in the scorpion Mesobuthus eupeus by cDNA cloning combined with biochemical approaches. Comparative modeling supports that all these KTxs share a conserved cysteine-stabilized α-helix/ß-sheet structural motif despite the differences in protein sequence and size. We investigated functional diversification of two orthologous α-KTxs (MeuTXKα1 from M. eupeus and BmP01 from Mesobuthus martensii) by comparing their K(+) channel-blocking activities. Pharmacologically, MeuTXKα1 selectively blocked Kv1.3 channel with nanomolar affinity (IC(50), 2.36 ± 0.9 nM), whereas only 35% of Kv1.1 currents were inhibited at 3 µM concentration, showing more than 1271-fold selectivity for Kv1.3 over Kv1.1. This peptide displayed a weak effect on Drosophila Shaker channel and no activity on Kv1.2, Kv1.4, Kv1.5, Kv1.6, and human ether-a-go-go-related gene (hERG) K(+) channels. Although BmB01 and MeuTXKα1 have a similar channel spectrum, their affinity and selectivity for these channels largely varies. In comparison with MeuTXKα1, BmP01 only exhibits a submicromolar affinity (IC(50), 133.72 ± 10.98 nM) for Kv1.3, showing 57-fold less activity than MeuTXKα1. Moreover, it lacks the ability to distinguish between Kv1.1 and Kv1.3. We also found that MeuTXKα1 inhibited the proliferation of activated T cells induced by phorbol myristate acetate and ionomycin at micromolar concentrations. Our results demonstrate that accelerated evolution drives affinity variations of orthologous α-KTxs on Kv channels and indicate that MeuTXKα1 is a promising candidate to develop an immune modulation agent for human autoimmune diseases.


Asunto(s)
Canales de Potasio/química , Venenos de Escorpión/química , Secuencia de Aminoácidos , Animales , ADN Complementario/genética , Drosophila , Canal de Potasio ERG1 , Canales de Potasio Éter-A-Go-Go/metabolismo , Biblioteca de Genes , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Datos de Secuencia Molecular , Oocitos/metabolismo , Escorpiones , Homología de Secuencia de Aminoácido , Xenopus
7.
Biochimie ; 92(12): 1847-53, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20713119

RESUMEN

Scorpion venom-derived peptidyl toxins are valuable pharmacological tools for investigating the structure-function relationship of ion channels. Here, we report the purification, sequencing and functional characterization of a new K(+) channel blocker (MeuKTX) from the venom of the scorpion Mesobuthus eupeus. Effects of MeuKTX on ten cloned potassium channels in Xenopus oocytes were evaluated using two-electrode voltage-clamp recordings. MeuKTX is the orthologue of BmKTX (α-KTx3.6), a known Kv1.3 blocker from the scorpion Mesobuthus martensii, and classified as α-KTx3.13. MeuKTX potently blocks rKv1.1, rKv1.2 and hKv1.3 channels with 50% inhibitory concentration (IC(50)) of 203.15 ± 4.06 pM, 8.92 ± 2.3 nM and 171 ± 8.56 pM, respectively, but does not affect rKv1.4, rKv1.5, hKv3.1, rKv4.3, and hERG channels even at 2 µM concentration. At this high concentration, MeuKTX is also active on rKv1.6 and Shaker IR. Our results also demonstrate that MeuKTX and BmKTX have the same channel spectrum and similar pharmacological potency. Analysis of the structure-function relationships of α-KTx3 subfamily toxins allows us to recognize several key sites which may be useful for designing toxins with improved activity on hKv1.3, an attractive target for T-cell mediated autoimmune diseases.


Asunto(s)
Bloqueadores de los Canales de Potasio/farmacología , Venenos de Escorpión/farmacología , Escorpiones/química , Secuencia de Aminoácidos , Animales , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Canal de Potasio Kv.1.2/genética , Canal de Potasio Kv.1.2/fisiología , Canal de Potasio Kv1.3/genética , Canal de Potasio Kv1.3/fisiología , Potenciales de la Membrana/efectos de los fármacos , Microinyecciones , Datos de Secuencia Molecular , Oocitos/efectos de los fármacos , Oocitos/metabolismo , Oocitos/fisiología , Técnicas de Placa-Clamp , Filogenia , Bloqueadores de los Canales de Potasio/clasificación , Bloqueadores de los Canales de Potasio/aislamiento & purificación , ARN Complementario/administración & dosificación , ARN Complementario/genética , Ratas , Venenos de Escorpión/genética , Venenos de Escorpión/aislamiento & purificación , Homología de Secuencia de Aminoácido , Xenopus laevis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA